logo
15:41 Dec 05

Procter & Gamble Health Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
5713.00
-141.00 (-2.41%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Procter & Gamble Health Ltd. Financials

Procter & Gamble Health Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
5713.00
-141.00 (-2.41%)
15:41 Dec 05
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

51/100
Technically Neutral

Strength

9

Weakness

6

Opportunity

1

Threats

1

43.65 %

ROE %

29.51 %

ROA %

184.83

EPS

323.47

BVPS

0.00 %

Net Profit Margin

Jun 2022 Jun 2023 Jun 2024 Mar 2025 TTM 2025
Net Sales
1114.41 1229.62 1151.26 934.17 1272.91
Operating Expenses +
846.73 904.94 845.26 615.78 864.18
Raw Material
344.55 358.99 329.69 247.75 331.6
Increase Decrease in Cost
-4.75 2.85 0.87 14.75 24.89
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
167.56 206.17 215.16 142.06 198.07
Miscellaneous Expenses
381.03 416.45 378.46 305.54 309.62
Operating Profit
267.68 324.68 306 318.39 408.73
Other Income
13.19 18.39 15.63 10.35 14.38
Depreciation
27.08 28.1 27.4 16.69 22.13
Interest
0.42 0.77 0.72 0.43 0.55
Profit before tax and exceptio..
253.37 314.2 293.51 311.62 400.43
Exceptional Items
0 0 -20.19 0 0
PBT
253.37 314.2 273.32 311.62 400.43
Provision for Taxation
60.85 84.73 72.34 77.21 99.84
Net Profit
192.52 229.47 200.98 234.41 300.59
NET Profit after MI
0 0 0 0 0
EPS
116 138 133 141 181.09
Operating Profit Margin (%)
24.02 26.4 26.58 34.08 32.11
Net Profit Margin (%)
17.28 18.66 17.46 25.09 23.61

Procter & Gamble Health Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 51.80 51.80 51.80 51.80 51.80 51.80
FII 7.20 7.00 6.90 7.00 6.60 6.40
Public 13.90 14.10 14.20 14.70 14.80 14.60
Others 27.10 27.10 27.10 26.50 26.80 27.20
Shareholder Shares Holding %
Research 360 logo
Download Our App On: